ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 92 filers reported holding ALLOVIR INC in Q3 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,844 | -36.8% | 21,323 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $72,498 | +10.1% | 21,323 | +27.6% | 0.00% | – |
| Q1 2023 | $65,837 | -23.2% | 16,710 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $85,722 | -35.0% | 16,710 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $131,842 | +8.2% | 16,710 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $121,851 | -21.0% | 18,052 | +51.5% | 0.00% | 0.0% |
| Q4 2021 | $154,193 | -48.4% | 11,916 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $298,615 | +27.0% | 11,916 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $235,222 | -15.6% | 11,916 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $278,834 | -9.6% | 11,916 | +48.5% | 0.00% | 0.0% |
| Q4 2020 | $308,366 | +39.8% | 8,022 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $220,605 | – | 8,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |